‘Diabetes + hyperlipidemia’ combination therapy market fueled with 3 new products

Published: 2018-05-15 16:29:00
Updated: 2018-05-15 22:03:26

The market of diabetes and hyperlipidemia has been fueled.

On the 10th, the Ministry of Food and Drug Safety(MFDS) approved CJ HealthCare’s Atomet SR Tab 10/500mg, 10/750mg, 20/500mg and 20/750mg, Daewoong Pharmaceutical’s Lipimet SR Tab 10/500mg, 10/750mg, 20/500mg and 20/750mg, Jeil’s Limitor ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean





TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.